Differences in the immunogenicity of leukemia L1210 sublines in DBA-2 mice.
D000813:Anilides / Q000627:therapeutic use; D000818:Animals; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002460:Cell Line / Q000187:drug effects / Q000276:immunology*; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006147:Guanine / Q000627:therapeutic use; D006835:Hydrazones / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy / Q000276:immunology*; D051379:Mice; D008815:Mice, Inbred Strains; D011830:Radiation Effects; D014508:Urea / Q000627:therapeutic use
D000813:Anilides; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D006835:Hydrazones; D007093:Imidazoles; D003561:Cytarabine; D006147:Guanine; D014508:Urea